Bildkälla: Stockfoto

Egetis Therapeutics: A short-cut to the market - Redeye

Redeye comments on the revised regulatory strategy for marketing authorization for Emcitate, announced by Egetis this morning.

Redeye comments on the revised regulatory strategy for marketing authorization for Emcitate, announced by Egetis this morning.
Börsvärldens nyhetsbrev
ANNONSER